stars 1 stars 2 stars 3

Kineta completed a reverse merger with Yumanity Therapeutics with Kineta, Inc. as the surviving company effective December 19, 2022.

View Top Employees from Yumanity Therapeutics
Revenue $20 million
Funding $46 million
Employees 7 (7 on RocketReach)
Founded 2014
Address 40 Guest St Ste 4410, Boston, Massachusetts 02135, US
Phone (617) 409-5300
JavaScript, HTML, PHP +11 more (view full list)
Category Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Therapeutics
Web Rank 13 Million
Keywords c4 therapeutics, yumanity therapeutics, tony coles onyx, yumanity, reports on yumanity therapeutics
Competitors Alkahest, Inc., Amylyx Pharmaceuticals, Cognition Therapeutics, Inc., Foldrx Pharmaceuticals, Neuraltus Pharmaceuticals
SIC SIC Code 87 Companies, SIC Code 873 Companies
NAICS NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies

Yumanity Therapeutics Questions

The Yumanity Therapeutics annual revenue was $20 million in 2024.

Tony Coles is the Chairman of Yumanity Therapeutics.

7 people are employed at Yumanity Therapeutics.

Yumanity Therapeutics is based in Boston, Massachusetts.

The NAICS codes for Yumanity Therapeutics are [54171, 54, 5417, 541714, 541].

The SIC codes for Yumanity Therapeutics are [87, 873].

Top Yumanity Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users